![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Background: Alitretinoin (9-cis-retinoic acid) is a unique panagonist retinoid, capable of binding to all six known retinoid receptors (RAR-α, -β, -γ, and RXR-α, -β, -γ). Studies are being carried out to determine how best to utilize this characteristic in treatments for conditions such as chronic hand dermatitis. Objective: To review the literature on alitretinoin. Methods: The scope of the review encompasses ways that alitretinoin is currently and may potentially be utilized. Results/conclusions: Orally administered alitretinoin is a safe and effective treatment for chronic hand dermatitis. Topical treatment with alitretinoin can be expanded into other areas such as photoaged skin and cutaneous T-cell lymphoma. Despite these benefits, oral alitretinoin will face a difficult path attaining approval for use in the US.